Skyhawk Therapeutics began trialling the novel drug, SKY-0515, on New Zealand and Australian patients a year ago and plans to expand globally.
‘Are we animals in the zoo?’: Swiatek calls for player privacy at Australian Open
...
Read moreDetailsHome » US firm trialling Huntington’s disease treatment says it shows promising early results
Skyhawk Therapeutics began trialling the novel drug, SKY-0515, on New Zealand and Australian patients a year ago and plans to expand globally.
...
Read moreDetails